Scandinavian ChemoTech AB receives final injunction on EU patent for its technology platform for dynamic electroporation
ChemoTech has received a 71(3), also called final injunction, from the European Patent Office, which announces that one of the company's European patent applications will be approved.The patent, to which the final injunction applies, covers both the unique design and functionality of the hand probe and the unique treatment kit. This patent also includes the technology that makes the TSE pulses rotate between the different electrodes. This function means that the TSE treatment reduces the risk of cancer cells surviving the treatment due to so-called "Cold Spots" (tissue not reached by the